Crossmark

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-995

Published Online: 2014-12-23

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Davis, Jillian

Martin, Stewart G

Patel, Poulam M

Green, Andrew R

Rakha, Emad A

Ellis, Ian O

Storr, Sarah J
License Information

License valid from 2014-12-01
More Information

Article History

Received: 15 September 2014

Accepted: 16 December 2014

First Online: 23 December 2014